Valuation: Evogene Ltd.

Market Cap 4.07M 1.22B 3.58M 3.3M 3.09M 5.78M 384M 5.91M 39.6M 15.32M 190M 15.29M 14.95M 659M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 4.07M 1.22B 3.58M 3.3M 3.09M 5.78M 384M 5.91M 39.6M 15.32M 190M 15.29M 14.95M 659M EV / Sales 2026 *
2.74x
EV / Sales 2027 * 1.57x
Free-Float
82.9%
Yield 2026 *
-
Yield 2027 * -
1 day-2.82%
1 week-26.41%
Current month-40.55%
1 month-42.50%
3 months-54.66%
6 months-64.38%
Current year-60.98%
1 week 115.1
Extreme 115.1
181.3
1 month 115.1
Extreme 115.1
248
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
499
3 years 115.1
Extreme 115.1
6,104
5 years 115.1
Extreme 115.1
11,900
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 30/11/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 31/12/2021
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 02/06/2010
Chairman 60 31/05/2021
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Executive/Senior Manager

20,000 0.2294%
03-17Other

Director

18,900 0.2168%
03-17Other

Chairman

21,025 0.2412%
Change 5-day change 1-year change 3-year change Capi.($)
-2.82%-26.41%-74.31%-97.16% 4.07M
-0.48%+7.20%-5.65%+3.69% 46.2B
+2.19%+11.71%+393.31%+609.31% 38.71B
+2.53%+13.93%+21.38%-10.96% 31.9B
+1.65%+3.61%+16.04%+55.24% 31.12B
-4.16%-2.58%+8.94%+26.14% 23.77B
-0.32%+12.96% - - 16.2B
+1.37%+14.53%+69.64%+136.34% 15.05B
+1.00%+10.30%+13.31%+23.36% 13.74B
+3.63%+9.53%+103.97%+106.25% 13.42B
Average +0.46%+5.58%+60.74%+94.69% 23.01B
Weighted average by Cap. +0.75%+8.71%+88.74%+138.12%

Financials

2026 *2027 *
Net sales 1.48M 445M 1.3M 1.2M 1.12M 2.11M 140M 2.15M 14.43M 5.58M 69.14M 5.57M 5.45M 240M 2.6M 780M 2.28M 2.11M 1.97M 3.69M 245M 3.77M 25.29M 9.78M 121M 9.76M 9.55M 421M
Net income -16.69M -5B -14.66M -13.52M -12.65M -23.68M -1.58B -24.2M -162M -62.8M -777M -62.66M -61.28M -2.7B -13.92M -4.17B -12.22M -11.27M -10.55M -19.75M -1.31B -20.18M -135M -52.36M -648M -52.25M -51.1M -2.25B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
26/06/26 ILA 117.30 -2.82% 67,029
25/06/26 ILA 120.70 -6.14% 258,699
24/06/26 ILA 128.60 -13.40% 725,460
23/06/26 ILA 148.50 -5.53% 53,862
22/06/26 ILA 157.20 -1.38% 26,444

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock